Xiao, J.; Han, Q.; Yu, Z.; Liu, M.; Sun, J.; Wu, M.; Yin, H.; Fu, J.; Guo, Y.; Wang, L.;
et al. Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway. Pharmaceuticals 2023, 16, 1438.
https://doi.org/10.3390/ph16101438
AMA Style
Xiao J, Han Q, Yu Z, Liu M, Sun J, Wu M, Yin H, Fu J, Guo Y, Wang L,
et al. Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway. Pharmaceuticals. 2023; 16(10):1438.
https://doi.org/10.3390/ph16101438
Chicago/Turabian Style
Xiao, Jirimutu, Qiuge Han, Ziceng Yu, Mengmin Liu, Jie Sun, Mao Wu, Heng Yin, Jingyue Fu, Yang Guo, Lining Wang,
and et al. 2023. "Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway" Pharmaceuticals 16, no. 10: 1438.
https://doi.org/10.3390/ph16101438
APA Style
Xiao, J., Han, Q., Yu, Z., Liu, M., Sun, J., Wu, M., Yin, H., Fu, J., Guo, Y., Wang, L., & Ma, Y.
(2023). Morroniside Inhibits Inflammatory Bone Loss through the TRAF6-Mediated NF-κB/MAPK Signalling Pathway. Pharmaceuticals, 16(10), 1438.
https://doi.org/10.3390/ph16101438
